Insider filing · ACAD
Elizabeth H.Z. Thompson
EVP, Head of Research & Dev
profile →
ACADIA Pharmaceuticals Inc.
ACAD · Healthcare · 12 filings in 24 months
ticker →
Elizabeth H.Z. Thompson sold $431K of ACADIA Pharmaceuticals (ACAD)
Executed Jul 30, disclosed Jul 31, 1 day later.
Value, as filed
$431K
16,508 sh × $26.13
Executed
Jul 30
the trade date, as filed
Disclosed
Jul 31
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
ETElizabeth H.Z. Thompson (EVP, Head of Research & Dev) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in ACADIA Pharmaceuticals Inc. (ACAD). The largest single filing was $431K of ACAD (16,508 sh × $26.13, as filed), executed Jul 30.
The name
ACADHealthcare · ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for neurological an…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→